CTMX earnings

CytomX Therapeutics (CTMX) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.

CTMX earnings history

QuarterReportedEPSEstimateSurpriseRevenue
Q3 2026Nov 5, 2026-0.09––$1.69M
Q2 2026Aug 6, 2026-0.09––$1.42M
Q1 2026May 7, 2026-0.10––$10.26M
Q4 2025Mar 16, 2026-0.22––$663.00K
Q3 2025Nov 6, 2025-0.09-0.05-82.52%$5.96M
Q2 2025Aug 7, 2025-0.00-0.0698.11%$18.66M
Q1 2025May 12, 20250.270.12116.35%$50.92M
Q4 2024Mar 6, 20250.22––$38.09M
Q3 2024Nov 7, 20240.07––$33.43M
Q2 2024Aug 8, 2024-0.08-0.1442.86%$25.11M
Q1 2024May 8, 20240.17-0.08312.50%$41.46M
Q4 2023Mar 11, 20240.01-0.03133.33%$26.61M
Q3 2023Nov 7, 20230.04-0.19121.05%$26.38M
Q2 2023Aug 8, 2023-0.02-0.2090.00%$24.72M
Q1 2023May 9, 2023-0.05-0.1154.88%$23.50M
Q4 2022Mar 27, 2023-0.43-0.24-79.17%$20.12M
Q3 2022Nov 8, 2022-0.35-0.31-12.90%$11.15M